Shintaro Akiyama
Overview
Explore the profile of Shintaro Akiyama including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
80
Citations
814
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Akiyama S, Hayashi R, Takasago T, Kusunoki K, Ikeuchi H, Takenaka K, et al.
J Gastroenterol
. 2025 Mar;
PMID: 40050487
Background: Endoscopic phenotypes of pouchitis according to the Chicago Classification have been reported to be associated with poor pouch outcomes in ulcerative colitis (UC). Here, we aimed to assess the...
2.
Olivas A, Ngai P, Schahrer E, Olortegui K, Cursio J, Akiyama S, et al.
bioRxiv
. 2025 Feb;
PMID: 39974918
Background And Aims: Total abdominal colectomy (TAC) with a staged ileal pouch-anal anastomosis (IPAA) is a common surgical treatment for ulcerative colitis (UC). However, a significant percentage of patients experience...
3.
Naganuma M, Shiga H, Shimoda M, Matsuura M, Takenaka K, Fujii T, et al.
J Gastroenterol
. 2025 Jan;
PMID: 39883201
Background: Despite the availability of several biologics for ulcerative colitis (UC), there remains a critical need to identify first-line treatment biologics. The superiority of infliximab (IFX) over vedolizumab (VED) and...
4.
Akiyama S, Fujii T
Aliment Pharmacol Ther
. 2025 Jan;
61(5):921-922.
PMID: 39846153
No abstract available.
5.
Akiyama S, Fujii T
Aliment Pharmacol Ther
. 2025 Jan;
61(4):737-738.
PMID: 39780440
No abstract available.
6.
Akiyama S, Nishijima S, Kojima Y, Kimura M, Ohsugi M, Ueki K, et al.
Nat Commun
. 2024 Nov;
15(1):10291.
PMID: 39604394
The integrative multi-kingdom interaction of the gut microbiome in ulcerative colitis (UC) and Crohn's disease (CD) remains underinvestigated. Here, we perform shotgun metagenomic sequencing of feces from patients with UC...
7.
Akiyama S, Shimizu H, Tamura A, Yokoyama K, Sakurai T, Kobayashi M, et al.
Aliment Pharmacol Ther
. 2024 Nov;
61(3):524-537.
PMID: 39578704
Background: Three Janus kinase (JAK) inhibitors are approved for ulcerative colitis (UC) in Japan. Aim: To compare the real-world efficacy and safety of these three JAK inhibitors in UC. Methods:...
8.
Akiyama S, Cohen N, Ollech J, Traboulsi C, Rodriguez T, Rai V, et al.
Crohns Colitis 360
. 2024 Sep;
6(3):otae045.
PMID: 39347443
Background: The modified pouchitis disease activity index (mPDAI) based on clinical symptoms and endoscopic findings is used to diagnose pouchitis, but validated instruments to monitor pouchitis are still lacking. We...
9.
Akiyama S, Ollech J, Cohen N, Traboulsi C, Rai V, Glick L, et al.
Inflamm Bowel Dis
. 2024 Jun;
31(1):63-71.
PMID: 38916136
Background: Patients with inflammatory bowel disease (IBD) who undergo proctocolectomy with ileal pouch-anal anastomosis may develop pouchitis. We previously proposed a novel endoscopic classification of pouchitis describing 7 phenotypes with...
10.
Ogata Y, Soeda A, Saura I, Nemoto E, Tange Y, Enami C, et al.
Nihon Shokakibyo Gakkai Zasshi
. 2024 Jun;
121(6):481-488.
PMID: 38853017
Pyoderma gangrenosum (PG) is a sterile inflammatory skin condition that is frequently associated with immune-related diseases, including inflammatory bowel disease (IBD). PG causes noninfectious ulcers. Facial PG is uncommon while...